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1. Introduction 
Decades ago acute pancreatitis was thought to be an unusual disease in children; therefore 
the diagnosis was delayed or even misdiagnosed. Recent published information regarding 
its incidence, etiological factors and clinical characteristics suggest two important issues: its 
prevalence and incidence seem to increase in the last decade and the concept of a benign 
entity has been challenged by the high proportion of cases with necrotic-hemorrhagic 
lesions demonstrated by image studies and the relatively frequent occurrence of relapses 
(1,2). It is not clear if these published data mean an actual increasing incidence or reflect the 
fact that pediatricians are testing more frequently for this disease. An increase in the number 
of cases of pancreatitis in children has been demonstrated by authors in the USA (2-8), 
Australia (9), Poland (10), México (11-13), and Taiwan (14). 
2. Definition  
The National Library of Medicine defines pancreatitis as an inflammatory disorder of the 
pancreas (http://www.ncbi.nlm.nih.gov).  In order to diagnose pancreatitis at least two of 
the following criteria are required: 1) an increase in serum amylase >3 normal (>330 U/L) or 
in serum lipase >3 normal (>900 U/L); 2) clinical signs and symptoms consistent with the 
diagnosis (abdominal pain, vomiting, ileus and other signs like fever and jaundice); and 3) 
evidence of edema or hemorrhage and necrosis of the pancreas by ultrasonography and/or 
computed tomography (CT) (15). According to its evolution, pancreatitis may be classified 
as acute when it lasts days or a few weeks and is a reversible process. The term recurrent is 
used when more than one episode of acute pancreatitis occurs. Chronic pancreatitis implies 
the presence of pancreatic morphologic changes and losses of the exocrine and endocrine 
function that are not reversible. 
3. Pathophysiology and etiology 
Pancreatitis results from injury and inflammation of the pancreas that may be extended to 
peri-pancreatic tissues and remote organs. The process requires an initiating event that 
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triggers the acinar cells and activates the intracellular trypsinogen and other digestive 
enzymes. The resultant acinar cell damage produces pancreatic edema and a local 
inflammatory response associated with the release of inflammatory mediators (6,15-17). 
In most cases of pancreatitis more than one etiological factor may be indentified; from this 
point of view pancreatitis is better defined as a complex multifactorial disease (Figure 1).  
 
 
Fig. 1.  Etiologic factors associated to pancreatitis. AP: acute pancreatitis; RP: recurrent 
pancreatitis; CP: chronic pancreatitis. 
Studies performed in adults have described that the prevalence of the etiological factors 
have changed with time: the frequency of alcoholic induced chronic pancreatitis has 
decreased, biliary tract disease accounts for a higher percentage and etiologies as 
autoimmune and particularly hereditary/genetic pancreatitis are reported with increasing 
frequency (17-19). 
In children, the spectrum of factors associated to pancreatitis is very broad. The etiological 
factors identified in some pediatric series are described in Table 1; the most common are 
biliary tract disease (cholelitiasis, lithogenic bile, choledocal cyst, sphincter of Oddi 
dysfunction), abdominal trauma, drug ingestion and viral infections. The family history of 
pancreatitis is an important etiological factor that has to be asked, since hereditary 
pancreatitis may be defined as two patients with history of pancreatitis within one 
generation or more than two patients in more than one generation (20). In 7.2 to 37.6% of 
children with acute pancreatitis, no etiological factors are identified and these cases are 
classified as idiopathic (3-5,9,10,14,21-25).  
Another issue regarding etiology is the genetics of pancreatic disease. Recent evidence 
suggests that a significant proportion of cases with idiopathic pancreatitis, particularly 
recurrent and chronic, may be associated to mutations. The first pancreatitis susceptibility 
gene discovered was PRSS1 (protease, serine 1). Mutations in PRSS1, which encodes cationic 
trypsinogen, were discovered in families with hereditary pancreatitis (26-28) and the most 
common PRSS1 mutation  results in an Arg122 His substitution, which eliminates the key 
autolysis site that allows for rapid trypsin self-destruction in solutions with a low calcium 
concentration, such as inside the acinar cell (Whitcomb, 1996). This means that trypsin 
activation and prolonged survival inside the acinar cell leads to pancreatitis due to a 
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premature trypsinogen activation and persistent trypsin activity as being key initiators of 
pancreatic injury, because all of the zymogens are activated by trypsin and thereby increase 
susceptibility to acute and chronic pancreatitis (29).  
 












2002 61 11.4  - 45.9 6.6  1.6 14.7 - 19.7 
López 2002 274 10 - - 19 5 - - 53 - 17 
Pezilli 2002 50 28 - 6 10 2 2 12 6 - 34 
De Banto 2002 202 6.4 2.5 6.9 14.4 10.4 3.5 2.5 6.4 2.5 37.6 
Werlin 2003 180 12.2 3.3 - 13.9 12.2 6.1 7.2 13.9 2.8 7.2 
Choi 2003 56 29 2 - 11 30 -  9 - 12 
Alvarez 2003 31 16.1 3.2 - 6.5 9.7 3.2 19.3 6.5 - 35.5 
Sobczynska-
Tomaszewska 
2006 92 10.9 15.2 27.2 5.4 - 8.7 2.2 4.3 33.7 29.3 
Nydegger 2007 279 5.4 - - 36.3 3.2 5.8 2.2 22.2 - 25.1 
Kandula 2008 87 5.7 - - 8.0 8 - 21.8 34.5 - 21 
Sánchez- 
Ramírez 
2011 92 25 4.3 14.1 20 18.5 17.4 3.3 12 9.8 36.8 
Table 1. Etiologic factors in 11 series of children with pancreatitis. Results are presented as 
percentages. 
If trypsinogen becomes prematurely activated, a small fraction is directly inhibited by a 
pancreatic secretory trypsin inhibitor (PSTI), which is also known as serine protease 
inhibitor Kazal-type 1 (SPINK1). The importance of this specific trypsin inhibitor is that 
patients with mutated SPINK1 develop recurrent acute and chronic pancreatitis.(30-32). 
Another gene associated to the development of pancreatitis is the cystic fibrosis 
transmembrane conductance regulator (CFTR), which is a regulated anion channel that is 
located at the luminal surface of the duct cell and the key molecule in the pancreatic duct 
responsible for fluid secretion. The loss of bicarbonate secretion in the duct caused by CFTR 
mutations confers a less alkaline pancreatic juice that does not inhibits activated trypsin by 
interfering with the transition between trypsinogen and trypsin (33-35) and the ability to 
flush active enzymes out of the duct may be lost. The CFTR also protects the pancreas by 
quickly sweeping zymogens out of the pancreas. In 1998, two groups (34,35) demonstrated 
that CFTR mutations were also common in idiopathic and alcoholic chronic pancreatitis, 
which indicates that some of the 1,250 known CFTR gene sequence variants cause 
pancreatitis, particularly ∆F508 in which a three-base pair deletion causes loss of 
phenylalanine 508 and represents about 70% of CFTR mutations worldwide (36). The 
detection of mutations in the genes associated to pancreatitis is important since it has been 
demonstrated by other authors that the interaction of environmental and genetic factors (i.e. 
N34S + alcohol or PRSS1 + smoking) further increased the probability of a disease (20). 
The majority of the cases with mutations in genes associated to pancreatitis get ill in 
childhood. However, in a significant number of cases the definite signs of chronic 
pancreatitis may be found only after a long follow-up period. Keim describes that 
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approximately 80% of patients with SPINK1 mutations showed at least one of the definite 
signs of chronic pancreatitis after a follow-up time of 15 to 20 years. In 50% of the patients 
with a PRSS1 mutation, chronic pancreatitis may be diagnosed after 25 years of follow up. In 
addition, it has been demonstrated a geographical variation regarding etiology, particularly 
genetic variants.  
The genetic variants (20) performed in pediatric population are very few compared to the 
studies performed in adult population. The mutations associated to pancreatitis that have 
been identified in some pediatric series are described in Table 2. There is a trend of a higher 
proportion of mutations in patients with RP and CP than in AP, although most of the 
studies included only patients with RP and CP and not cases with AP (10,31,37,38). 
In a pediatric series of 92 children with AP and RP attended at the Hospital of Pediatría 
(Guadalajara, México), we identified mutations (R122H and N34S) in a group of AP 
exclusively; this represented a 13-fold increased risk of having AP compared with the 
general population in which we did not identified these mutations. The SPINK1 N34S 
mutation was identified in 3/58 cases with AP, none in the group of RP nor in general 
population and it was found that the cases bearing the SPINK1 N34S G allele exhibited a 10-
fold increased risk of developing AP compared with the general population, suggesting that 
the SPINK1 N34S mutation represents an etiological risk factor for the development of AP in 
our pediatric patients (25).  
It is important to highlight that genetic testing in children with pancreatitis is not only 
useful for diagnosis but also as a predictive factor as it helps to identify individuals at risk 
for a more severe course of the disease. 
4. Clinical, laboratory and image data 
A summary of studies that report the frequency of the symptoms and signs in children with 
pancreatitis is presented in Table 3. The most common symptoms were abdominal pain 
followed by vomiting; in our series, ileus reached almost one-half of the cases studied 
(1,39,40). Abdominal pain is less commonly observed in children younger than 2 years, since 
it may be manifested by irritability (24,41). 
In pediatric series with pancreatitis an elevation of serum amylase has been reported in 83.6 to 
85.5% of the cases and of serum lipase in 82 to 90% (1,5,14). Although it has a relatively low 
sensitivity and specificity (75 to 92% and 20 to 60%, respectively), serum amylase remains as 
the test most frequently used to confirm pancreatitis. Serum amylase begins to increase 2 to 12 
hours after the pancreatic insult and peaks at 12 to 72 hours after the onset of symptoms. 
Sensitivity and specificity of serum lipase is 86-100% and 50-99% respectively. By increasing 
the cutoff level to greater than three times the upper normal limit, sensitivity may increase to 
100% and specificity to 99%. Lipase level remains elevated for a longer period of time in the 
plasma than amylase; increase occurs within 4 to 8 hours after symptom onset, peaks at 24 
hours and decreases over 8 to 14 days. By using serum amylase and lipase determinations 
together, clinical sensitivity for the diagnosis of pancreatitis increases to 94% (15). 
Imaging studies are a crucial tool to perform the diagnosis of pancreatitis. Ultrasound (US) 
is the primary imaging modality. However, the pancreas size is age-dependent and its 
echogenicity is variable; its reliability to identify pancreatitis seems to be higher in children. 
The US sensitivity in adults is 62-67% for acute and 50-80% for chronic pancreatitis, 
respectively (42). To our knowledge, in children there are no studies assessing the accuracy 
of US in the diagnosis of pancreatitis. The computed tomography (CT) provides additional 
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information about potential etiologies besides the presence of necrosis and other 
complications (6); however, it involves radiation exposure and has poor sensitivity in 
detecting ductal abnormalities (6,43). The CT with IV contrast is useful to identify necrotic-
hemorrhagic areas, fluid collections and peri-pancreatic inflammation; as pancreatic necrosis 
occurs 24 to 48 hour after the symptom onset it is recommended to perform the CT 48 to 72 
hours after pain or vomiting appeared. In two pediatric series, CT identified abnormalities 
more frequently than US (1, 14).  
 
Study Year Patients 
(n) 
Clinical signs and symptoms (%) 
Abdominal 
pain 
Vomiting Ileus Fever Jaundice 
Mao-Meng Tiao, et al. 2002 61 95 37.7 - 29.5 |3.2 
Pezzilli et al. 2002 50 96 - - - - 
Alvarez, et al. 2003 31 90 38 - 9.6 - 
Werlin, et al. 2003 214 67.8 44.9 - - - 
Sánchez-Ramírez, et al. 2007 55 94.5 85.5 47.3 27.3 9.1 
Table 2. Mutations associated to acute (AP), recurrent (AR) or chronic (CP) pancreatitis in 
624 children from different countries. Results are presented in percentages. 
 
Author (year) Country n 
SPINK (%) PRSS1 (%) 








164 - 20.7 - 4.2 
Sobczynska-
Tomaszewska (2006) 
Poland 92 - 8.7 - 9.2 
Werlin (2003) USA 180 0.6 1.2 - 1.1 
Sanchez-Ramírez (2011) México 92 5.2 - 1.7 - 
Table 3. Clinical characteristics in 411 children with pancreatitis from five pediatric series. 
Values of clinical signs and symptoms are presented as percentages. 
The magnetic resonance cholangio-pancreaticography is non-invasive and do not expose the 
patients to radiation. It may provide a comprehensive morphological description of the 
biliary and pancreatic duct, making the endoscopic retrograde cholangio-pancreaticography 
(ERCP) unnecessary for diagnostic purposes (43). 
5. Disease spectrum 
Acute pancreatitis should be thought as an event and chronic pancreatitis as a process (16). 
Recurrent pancreatitis could be considered as a transition state until definite signs of chronic 
pancreatitis are detectable (20).The disease spectrum of pancreatitis is variable, ranging from 
mild edematous to severe fulminant pancreatitis, with potentially devastating complications.  
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DeBanto et al. (4) proposed a scoring system to predict the severity of pancreatitis in 
children. This scoring may permit to estimate the probability of having or not a severe 
disease; children who have a score of ≥3 on admission should be sent to a "step down" unit 
for close monitoring; if they reached the 48-h point with a score of ≤2, they would be 
transferred to a regular ward bed. 
This scoring system has eight parameters, four to be scored on admission and four by 48h. 
The criteria for admission to an intensive care unit from the emergency room are: age <7 yr, 
weight <23 kg, white blood cell count >18,500 and lactic dehydrogenase >2,000. The 48h 
criteria are calcium <8.3 mg/dL, albumin <2.6 g/dL, fluid-sequestration >75 ml/kg/48 h 
and a rise in blood urea nitrogen >5 mg/dL. 
6. Treatment 
Once the diagnosis of acute pancreatitis has been confirmed, the approach during the acute 
phase is initially directed to maintain the homeostasis by means of an IV fluid, electrolyte 
and glucose infusion according to the patients needs for age, hydration status and 
electrolyte balance. An adequate hemodynamic condition will prevent ischemia and 
pancreatic necrosis. The cases with abdominal CT suggestive of severe hemorrhagic 
pancreatitis should be admitted to an intensive care unit; the DeBanto’s score system on 
admission and at 48 hours may help the clinician to decide the admission to intensive care. 
A nasogastric tube with drainage by gravity will help to decompress the bowel and may 
improve the abdominal pain as well as the vomiting; in patients with ileus the nasogastric 
drainage will have intestinal or even fecal aspect (42,44,45).  
Antibiotics are not recommended in all cases of children with acute pancreatitis. They 
should be used in the presence of biliary obstruction, pancreatic abscesses or in selected 
cases of necrotic-hemorrhagic pancreatitis. However, these recommendations have been 
outlined from adult series with pancreatitis; these criteria have been used somehow in 
children although systematic pediatric data are lacking (42,44,45). Management of 
abdominal pain is crucial as this symptom may be associated to an adverse outcome; 
narcotics are not recommended due to its potential effect on Oddi’s sphincter (45). 
Surgery may be indicated at least three weeks after the acute episode in patients with severe 
pancreatitis associated to extra-pancreatic fluid collections, abscesses and large pseudocysts 
(14,42). The surgical approach should be considered in particular cases. 
The core goals of treatment are to support the involution of the pancreatic inflammation and 
to prevent the activation of the pancreatic enzymes. A logical way to achieve this goal is to 
avoid the physiologic stimulus of pancreatic secretion, namely the presence of 
macronutrients in the stomach and in the proximal duodenum (46). In children, this 
approach implies parenteral or enteral nutritional support. 
Children with acute pancreatitis are at risk of acute malnutrition due to two conditions: a) 
an increase in energy and nutrient requirements related to their catabolic disease; and b) 
iatrogenic or spontaneous oral food restriction (47). The nutritional risk is inversely 
proportional to age as growth speed and energy/nutrient requirements are higher in 
younger children; this is a physiologic condition between catabolic states in children versus 
adults. 
Fasting in adults with mild acute pancreatitis is not recommended and oral feedings may be 
initiated when pain stops. No benefit of enteral  or parenteral nutrition has been 
www.intechopen.com
 Pancreatitis in Children 
 
61 
demonstrated in these patients (48). Parenteral or enteral nutrition have been widely used 
for more than two decades in adult patients when fasting must be prolonged beyond one 
week because the pancreatic inflammation persists or in the presence of hemorrhagic 
pancreatitis. Although these two modalities of nutritional intervention have shown their 
efficacy, evidence related to the advantages of enteral nutrition has gradually accumulated. 
The rationale for using enteral nutrition is that nutrient infusion ahead the duodenum 
diminishes or avoids the secretion of cholecystokinin, secretin and pancreozymin and 
consequently maintains a low pancreatic exocrine activity. However, there is controversy 
regarding the infusion site in the GI tract. Some authors have demonstrated that nasogastric 
infusion is a secure and well tolerated alternative although their data relate more to non-
severe pancreatitis (49-53). There are no published data regarding enteral nutrition with a 
nasogastric infusion in pediatric patients with pancreatitis. 
The European Society for Clinical Nutrition and Metabolism recommends initiating oral  after 
abdominal pain has disappeared, when amylase and lipase concentration are almost 
normal, gastric emptying is normal and complications were solved out (48,53). A non-
randomized study in adults with acute pancreatitis identified that 21% of patients presented 
a pain relapse and 12 day delay between onset of symptoms and oral refeeding. In a 
retrospective study in children with acute pancreatitis, 15.4% and 10.3% had recurrence of 
pain and amylasemia when oral feedings were started before the days 7th and 10th 
respectively (52,54,55). 
An elemental diet or formulas with oligopeptides seem the best options to achieve a 
maximum suppression of the pancreatic enzyme secretion (48,53); however, a recent meta-
analysis states that polymeric diets have similar efficacy in the nutritional support of adults 
with acute pancreatitis. In the last two decades a number of children with mild or severe 
pancreatitis have been managed with naso-jejunal enteral nutrition using an elemental diet 
with low recurrence and complication rates (54-57).   
Adults with pancreatitis have increased energy and protein requirements; this has been 
estimated between 30 to 50% above normal daily requirements (Meier 2006). In children with 
pancreatitis this increased needs have been assumed for parenteral or enteral nutrition during 
the disease. In a series of children with pancreatitis managed with home enteral nutrition and 
energy intake of about 80% of the daily energy requirements an actual loss of weight was 
observed along the 14th to the 21th day of the intrevention (55). In a recent open clinical trial in 
17 children with acute pancreatitis managed with enteral nutrition, an enteral energy supply of 
130% of daily energy requirements led to a stable weight along the trial and to a significant 
increase in serum albumin (57) . 
Enteral nutrition prevents the systemic inflammatory response, luminal stasis, bacterial 
overgrowth and bacterial translocation (58). Besides maintaining the “pancreatic rest”, 
enteral nutrition reduces the length and costs of hospitalization and the frequency of sepsis 
(59,60). In prospective studies it has been demonstrated that the early onset of enteral 
nutrition –within 48 hours after admission- actually prevents the severity of the pancreatic 
damage, maintains enteral function and improve oral tolerance.  
The proposal of nutritional intervention in children with acute pancreatitis is supported in 
several facts: a) prevents acute malnutrition; b) provides nutrients for tissue healing; and c) 
modulates the systemic inflammatory response and thus prevents multiple organic failure 
(59). Published data related to nutritional support in children with acute pancreatitis are 
scanty. In the experience of the authors of this chapter in dealing with children with acute 
pancreatitis for about two decades, some facts may be underlined: a) children with mild or 
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edematous pancreatitis managed NPO and IV saline/glucose solutions do present acute 
malnutrition with a loss of more than 1 standard deviation of weigh for height or triceps 
skinfold (13,39,54); b) fasting for less than 7 days has an increased risk of recurrence of 
abdominal pain, raise in amylase levels >3x and recurrence of US abnormalities in around 
20% of cases (13,54); c) sepsis is almost inexistent in children managed with enteral 
nutrition; d) it is feasible to handle home enteral nutrition even with families with parents 
with mid educational level (55); e) decrease in amylase levels and symptomatic 
improvement are similar in children managed with total parenteral nutrition versus enteral 
nutrition (55); d) acute malnutrition may be prevented with the infusion of ~ 130% of the 
daily recommended intake of energy and macronutrients (56,57). 
The suggested nutritional intervention protocol for children with acute pancreatitis is 
presented in Table 4. The enteral infusion may be initiated once the ileum is resolved (the 
nasogastric drainage is clear, peristalsis is normal and the patient is passing gas and stools), 
even in the presence of abdominal pain. The enteral tube must be located in the jejunum and 
the infusion should be continuous for 24 hours if the patient remains hospitalized or 
discontinued for six hours (from 24 PM to 6 AM) if the patient is managed at home. The 
energy target is 130% of daily recommended intake of energy for age and sex and the 
recommended formula is an elemental diet; the authors do not have experience with the 
management of semi-elemental or polymeric formulas. The large amount of fluids required 
to reach this goal are tolerated quite well (56-57).  
 
 
Enteral tube Naso-jejunal feeding tube (2-way, radio-opaque tube) 
Infusion site placed ahead the angle of Treitz (verify tube placement 
with abdomen X-ray) 
Tube marked with permanent ink at the nostril fixation level 
Enteral formula Elemental formula (free amino-acids, glucose polymers and essential 
fatty acids). 80g of formula = carbohydrate 63g, protein 12.6g and fat 
0.81g. 
Enteral infusion 24-hour continuous infusion in hospitalized patients, 18-hour 
infusion in home enteral nutrition.  
Initial infusion: 100% of DRI of energy for age and sex; increase 15% 
daily to a target of  130% 
Re-feeding Oral refeeding; edematous pancreatitis 7 days and severe pancreatitis 
14 days after de symptom onset (in absence of abdominal pain and 
serum amylase and lipase not higher than 2x)  
Re-feeding diet: Diet high in carbohydrate and moderate in fat and 
protein starting with 70% of energy DRI and increasing 10% daily to 
reach 100% DRI. 
DRI: Daily recommended intake 
Table 4. Enteral nutrition recommendations in children with acute pancreatitis. 
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